Early July FDA Updates
Jul 02, 2020•13 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
FDA ended June with 5 new approvals.
*selinexor for r/r DLBCL
*pembrolizumab for cutaneous squamous cell carcinoma
*pembrolizumab for MSI-h/dMMR met. colorectal cancer
*avelumab maintenance for met. bladder cancer
*SC trastuzumab/pertuzumab/hyaluronidase
For the best experience, listen in Metacast app for iOS or Android